Rheumatoid arthritis trials in Hong Kong

2 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 1Taking people
  A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.

  Where

  Pok Fu Lam

  Age

  18 years to 70 years

  People

  72 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT06916806 · EU 2024-519015-34-00
• Phase 4Taking people
  Effect of JAK Inhibitor on Erosion Healing in RA

  Where

  Hong Kong

  Age

  18 years to 65 years

  People

  60

  Run by

  Chinese University of Hong Kong

  See details and how to joinNCT05955066